Frontlight ResearchEarly access
CompletedNo phase
Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction
Key facts
- Who runs it
- George Washington University
- Where
- Washington D.C., United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 3 Jun 2024
- Ended
- 1 Feb 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Systane iLux Treatment
- Record updated
- 15 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age greater than 18 at the time of informed consent
- Must understand; be willing and able, and likely to fully comply with study procedures, visit schedule, and restrictions
- Upcoming scheduled senile cataract surgery
Who cannot take part
- Patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months
- Ocular surgery within the last 6 months
- Occlusion therapy with lacrimal or punctum plugs within the last 3 months
- Patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months)
- Previous application/administration of Systane iLux or LipiFlow treatment
- Patients with cicatricial lid margin disease
- Eyelid abnormalities
- Patients with an ocular surface abnormality that may compromise corneal integrity
- patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia
- Patients with permanent makeup or tattoos on their eyelids
Where in United States
- George Washington UniversityWashington D.C., United States
About the trial
What the trial wants to find out
This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.
The 2 groups in the trial
- Control: No Systane iLux TreatmentNo study treatment, for comparison
No Systane iLux treatment at baseline visit two weeks prior to cataract surgery.
- Systane iLux TreatmentTreatment being tested
Systane iLux administration at baseline visit two weeks prior to cataract surgery.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Efficacy of the Systane iLux System on Preoperative Cataract Patients on Dry Eye Disease Due to Meibomian Gland Dysfunction
- Record updated
- 15 May 2026